Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
Our analysis included 133 AML patients (60 females and 73 males, median age 62 years, range 16–85 years), diagnosed between April 1995 and October 2004. The diagnosis of AML was established according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback